Boothbay Fund Management’s Larimar Therapeutics LRMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-13,731
| Closed | -$29.5K | – | 1426 |
|
|
2025
Q1 | $29.5K | Hold |
13,731
| – | – | ﹤0.01% | 1142 |
|
|
2024
Q4 | $53.1K | Sell |
13,731
-2
| -0% | -$8 | ﹤0.01% | 1186 |
|
|
2024
Q3 | $90K | Sell |
13,733
-62,179
| -82% | -$407K | ﹤0.01% | 1272 |
|
|
2024
Q2 | $550K | Sell |
75,912
-26,982
| -26% | -$196K | 0.01% | 834 |
|
|
2024
Q1 | $781K | Sell |
102,894
-27,064
| -21% | -$205K | 0.02% | 719 |
|
|
2023
Q4 | $591K | Sell |
129,958
-17,245
| -12% | -$78.5K | 0.02% | 789 |
|
|
2023
Q3 | $581K | Buy |
+147,203
| New | +$581K | 0.01% | 807 |
|
|
2023
Q2 | – | Sell |
-23,468
| Closed | -$106K | – | 1831 |
|
|
2023
Q1 | $106K | Buy |
23,468
+4,047
| +21% | +$18.3K | ﹤0.01% | 1665 |
|
|
2022
Q4 | $80.2K | Buy |
+19,421
| New | +$80.2K | ﹤0.01% | 1596 |
|
|
2021
Q3 | – | Sell |
-10,163
| Closed | -$100K | – | 1829 |
|
|
2021
Q2 | $100K | Sell |
10,163
-37,870
| -79% | -$373K | ﹤0.01% | 1569 |
|
|
2021
Q1 | $702K | Buy |
+48,033
| New | +$702K | 0.03% | 619 |
|